4th Quarter - Report

DRUG POLICY ALLIANCE for DRUG POLICY ALLIANCE

Firm
Client
Income
—
Expenses
$84,867
Expense method
B: tax-exempt organisations, Internal Revenue Code section 6033(b)(8)

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

S. 1764, CARERS Act, issues related to medical marijuana. HR 2851, SITSA Act, issues related to synthetic drugs. Issues related to overdose.

LobbyistCovered position, as disclosed
MICHAEL LISZEWSKI —
GRANT SMITH —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 2851 (115th), S. 1764 (115th)

Budget/Appropriations BUD

Issues related to marijuana spending amendments.

LobbyistCovered position, as disclosed
MICHAEL LISZEWSKI New —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Law Enforcement/Crime/Criminal Justice LAW

S 1689, Marijuana Justice Act, sssues related to ending federal marijuana prohibition.

LobbyistCovered position, as disclosed
QUEEN ABIMBOLA ADESUYI —
GRANT SMITH —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.